Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
101.423,51
-1,21%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Chimerix Inc (CMRX) Chimerix Inc (CMRX) Notizie

Chimerix Inc

CMRX
3,99
0,16 (4,18%)
25 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/1/202522:01GLOBEChimerix Reports Inducement Grants Under Nasdaq Listing Rule..
13/1/202513:00GLOBEChimerix to Speak Today at The White House Cancer Moonshot..
10/1/202521:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202521:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202520:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202520:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202520:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202520:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202413:21EDGAR2Form 8-K - Current report
30/12/202413:00GLOBEChimerix Submits Dordaviprone New Drug Application for..
10/12/202415:55APSSmall Cap Soars On FDA Submission Plans
10/12/202414:49EDGAR2Form 8-K - Current report
09/12/202422:01GLOBEChimerix to Submit Dordaviprone for Accelerated Approval to..
06/12/202422:01GLOBEChimerix Reports Inducement Grants Under Nasdaq Listing Rule..
14/11/202422:20EDGAR2Form 8-K - Current report
11/11/202413:00GLOBEChimerix Announces Updated Phase 2 Response Assessment of..
07/11/202413:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:10EDGAR2Form 8-K - Current report
07/11/202413:00GLOBEChimerix Reports Third Quarter 2024 Financial Results and..
01/11/202412:00GLOBEChimerix to Report Third Quarter 2024 Financial Results and..
31/10/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202422:31GLOBEChimerix Reports Inducement Grant Under Nasdaq Listing Rule..
03/9/202413:00GLOBEChimerix to Present at H.C. Wainwright 26th Annual Global..
30/8/202422:05GLOBEChimerix Reports Inducement Grant Under Nasdaq Listing Rule..
13/8/202422:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/8/202413:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202413:03EDGAR2Form 8-K - Current report
13/8/202413:00GLOBEChimerix Reports Second Quarter 2024 Financial Results and..
09/8/202419:26EDGAR2Form 144 - Report of proposed sale of securities
09/8/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202413:00GLOBEChimerix to Report Second Quarter 2024 Financial Results and..
05/7/202422:05GLOBEChimerix Reports Inducement Grants Under Nasdaq Listing Rule..
30/5/202413:00GLOBEChimerix to Participate in Fireside Chat at Jefferies Global..
06/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
01/5/202413:00GLOBEChimerix Reports First Quarter 2024 Financial Results and..
24/4/202413:00GLOBEChimerix to Report First Quarter 2024 Financial Results and..
16/4/202422:05GLOBEChimerix Reports Inducement Grants Under Nasdaq Listing Rule..
21/3/202412:00GLOBEChimerix Appoints Marc D. Kozin to Board of Directors
29/2/202415:20EDGAR2Form S-3 - Registration statement under Securities Act of..
29/2/202414:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202413:58EDGAR2Form 8-K - Current report
29/2/202413:00GLOBEChimerix Reports Fourth Quarter and Year End 2023 Financial..
27/2/202413:00GLOBEChimerix to Present at TD Cowen 44th Annual Health Care..
22/2/202413:00GLOBEChimerix to Report Fourth Quarter and Year End 2023..
17/2/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202419:28EDGAR2Form 144 - Report of proposed sale of securities
14/2/202419:21EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 3,83 Min: 3,81 Max: 3,99
Chiusura: 3,83

La tua Cronologia

NASDAQ
CMRX
Chimerix
ASX
CVSNA
Cervantes
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network